Hajek, Peter http://orcid.org/0000-0001-9160-4296
Przulj, Dunja http://orcid.org/0000-0003-1133-8835
Pesola, Francesca http://orcid.org/0000-0002-2054-7930
Griffiths, Chris http://orcid.org/0000-0001-7935-8694
Walton, Robert
McRobbie, Hayden http://orcid.org/0000-0002-7777-1845
Coleman, Tim http://orcid.org/0000-0002-7303-4805
Lewis, Sarah http://orcid.org/0000-0001-5308-6619
Whitemore, Rachel
Clark, Miranda http://orcid.org/0000-0002-6179-046X
Ussher, Michael
Sinclair, Lesley http://orcid.org/0000-0002-2210-8181
Seager, Emily
Cooper, Sue
Bauld, Linda http://orcid.org/0000-0001-7411-4260
Naughton, Felix
Sasieni, Peter http://orcid.org/0000-0003-1509-8744
Manyonda, Isaac
Myers Smith, Katie http://orcid.org/0000-0003-1837-3924
Funding for this research was provided by:
DH | NIHR | Health Technology Assessment Programme (12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85, 12/57/85)
Article History
Received: 6 September 2021
Accepted: 31 March 2022
First Online: 16 May 2022
Change Date: 7 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-022-02099-1
Competing interests
: P.H. provided consultancy to and received research funding from Pfizer. D.P. received research funding from Pfizer. H.M. has received honoraria for speaking at smoking cessation educational events and sitting on an advisory board organized by Pfizer. All other authors have no competing interests.